Related Experiment Video
Updated: Aug 8, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Does the variant positivity and negativity affect the clinical course in COVID-19?: A cohort study
Erkan Yildirim1, Levent Kilickan2, Suleyman Hilmi Aksoy3,4
1Department of Thoracic Surgery, Hisar Intercontinental Hospital, Umraniye, Istanbul, Turkiye.
Insights
The UK variant of Coronavirus Disease 2019 (COVID-19) led to more severe early and late complications, including bilateral pneumonia and acute respiratory distress syndrome (ARDS). Invasive treatments like extracorporeal membrane oxygenation were more common in patients with the UK variant.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonology
Background:
- The emergence of SARS-CoV-2 variants, such as the UK variant, has impacted Coronavirus Disease 2019 (COVID-19) clinical presentation and outcomes.
- Understanding the differences in patient data and treatment approaches before and after the UK variant's prevalence is crucial for managing the pandemic.
Purpose of the Study:
- To compare clinical, laboratory, and demographic data of COVID-19 patients admitted to intensive care units (ICUs) before and after the UK variant's diagnosis.
- To describe the treatment strategies employed for COVID-19 patients in relation to the circulating variant.
Main Methods:
- A retrospective analysis of 159 COVID-19 patients admitted to the ICU between March 2020 and June 2021.
- Patients were categorized into two groups: variant negative (pre-December 2020) and variant positive (post-December 2020).
- Statistical analysis included comparison of early/late complications, demographics, symptoms, comorbidities, intubation, mortality, and treatments.
Main Results:
- The variant positive group showed higher rates of bilateral pneumonia, secondary gram (+) infection, pulmonary fibrosis, acute respiratory distress syndrome (ARDS), and septic shock.
- Unilateral pneumonia was more frequent in the variant negative group.
- Plasma exchange and extracorporeal membrane oxygenation were utilized more in the variant positive group, despite similar mortality and intubation rates.
Conclusions:
- The UK variant of COVID-19 is associated with a higher incidence of severe early and late complications, necessitating more invasive treatment modalities.
- While mortality and intubation rates did not significantly differ, the increased severity of complications in the variant positive group highlights the evolving challenges of COVID-19.
- The findings underscore the need for adaptive strategies in managing future pandemics and variant-specific infections.
Abstract:
The primary aim of the current study is to analyze the clinical, laboratory, and demographic data comparing the patients with Coronavirus Disease 2019 (COVID-19) admitted to our intensive care unit before and after the UK variant was first diagnosed in December 2020. The secondary objective was to describe a treatment approach for COVID-19. Between Mar 12, 2020, and Jun 22, 2021, 159 patients with COVID-19 were allocated into 2 groups: the variant negative group (77 patients before December 2020) and the variant positive group (82 patients after December 2020). The statistical analyses included early and late complications, demographic data, symptoms, comorbidities, intubation and mortality rates, and treatment options. Regarding early complications, unilateral pneumonia was more common in the variant (-) group (P = .019), whereas bilateral pneumonia was more common in the variant (+) group (P < .001). Regarding late complications, only cytomegalovirus pneumonia was observed more frequently in the variant (-) group (P = .023), whereas secondary gram (+) infection, pulmonary fibrosis (P = .048), acute respiratory distress syndrome (ARDS) (P = .017), and septic shock (P = .051) were more common in the variant (+) group. The therapeutic approach showed significant differences in the second group such as plasma exchange and extracorporeal membrane oxygenation which is more commonly used in the variant (+) group. Although mortality and intubation rates did not differ between the groups, severe challenging early and late complications were observed mainly in the variant (+) group, necessitating invasive treatment options. We hope that our data from the pandemic will shed light on this field. Regarding the COVID-19 pandemic, it is clear that there is much to be done to deal with future pandemics.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Bias in Epidemiological Studies
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Factors Affecting Illness
For instance, risk factors are connected to illness,...

